Mesco Pharmaceuticals Limited

BSE: 500274
Mesco Pharmaceuticals Limited - pharma in Nanital, Uttarakhand, India. FY 2026 financials and compliance.
CIN L24111UR1986PLC015895 Incorporated 12 August 1986 ROC Uttarakhand HQ Nanital, Uttarakhand, India
Active Listed - BSE: 500274 Public Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹19.74 Cr
Issued & subscribed
Open charges
None
Satisfied ₹10 Cr
Company age
40 yrs
Est. 1986
Last financials
Mar 2021
Balance sheet date

About Mesco Pharmaceuticals Limited

Data last updated: 11 March 2026

Mesco Pharmaceuticals Limited is a public limited company based in Nanital, Uttarakhand, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 12 August 1986, the company has been in operation for over 40 years.

Registered with ROC Uttarakhand under CIN L24111UP1986PLC015895. Listed on BSE: 500274.

Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹19.74 Cr. It is led by directors including Dhruv Dushyant Kumar Singh and Hawa Singh Chahar.

Last AGM: 29 September 2021. Financial statements filed for year ended 31 March 2021. Office: Upper Kesalton Tallital Nanital, Uttarakhand, India – 263001.

As per MCA filings, the company has satisfied charges of ₹10 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mescopharma.com.

Company Details of Mesco Pharmaceuticals Limited
CIN L24111UR1986PLC015895
Registration Number 015895
Incorporation Date 12 August 1986
ROC Uttarakhand
Listing Status Listed (BSE: 500274)
Company Status Active
Date of Last AGM 29 September 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
Key People
Dhruv Dushyant Kumar Singh Director Hawa Singh Chahar Director Rajesh Tibrewal Additional Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Upper Kesalton Tallital Nanital, Uttarakhand, India – 263001
  • Industry
    Pharma, Drug Formulation & Development
Company report
Mesco Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Mesco Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Mesco Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Mesco Pharmaceuticals Limited

Mesco Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): L24111UP1986PLC015895. The current CIN is L24111UR1986PLC015895, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24111UR1986PLC015895 Current
L24111UP1986PLC015895 Previous

Board of Directors of Mesco Pharmaceuticals Limited

Mesco Pharmaceuticals Limited is currently managed by 6 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Dhruv Dushyant Kumar Singh
Also directs: Pahardia Gold Mining Limited, Swadesh And International Exports Limited, Vogue International Agencies Private Limited and 4 more
Director 31 Jul 2020 5 Years 11 Months Current
Hawa Singh Chahar
Also directs: Mideast (India) Limited
Director 21 Jun 2019 7 Years 0 Months Current
Rajesh Tibrewal
Also directs: Mesco Kalinga Steel Limited, Mesco Hotels Limited, Mesco Mining Limited and 1 more
Additional Director 18 Nov 2024 1 Years 7 Months Current
View all directors

Financials of Mesco Pharmaceuticals Limited FY 2021 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Mesco Pharmaceuticals Limited

Open charges
₹0
Satisfied charges
₹10 Cr
Breakdown by lending institutions
The Industrial Finance Corporation of India₹10.00 Cr
Latest charge details
DateLenderAmountStatus
16 Mar 1995 The Industrial Finance Corporation of India ₹10 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Mesco Pharmaceuticals Limited

View historical data on people associated with Mesco Pharmaceuticals Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Mesco Pharmaceuticals Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Mesco Pharmaceuticals Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Mesco Pharmaceuticals Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Mesco Pharmaceuticals Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Mesco Pharmaceuticals Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Mesco Pharmaceuticals Limited

MSME Payment Delays by Mesco Pharmaceuticals Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Mesco Pharmaceuticals Limited

Subsidiaries & Group Companies of Mesco Pharmaceuticals Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Mesco Pharmaceuticals Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Mesco Pharmaceuticals Limited

MCA Filings & Documents of Mesco Pharmaceuticals Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Mesco Pharmaceuticals Limited

Directors
18 Nov 2024
Rajesh Tibrewal was appointed as a Additional Director on 18 Nov 2024 & has been associated with this company since 1 year 7 months.
Activity
29 Sep 2021
Mesco Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2021 as per latest MCA records.
Activity
31 Mar 2021
Mesco Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Uttarakhand.
Directors
31 Jul 2020
Dhruv Singh was appointed as a CEO on 31 Jul 2020 & has been associated with this company since 5 years 11 months.
Directors
31 Jul 2020
Dhruv Dushyant Kumar Singh was appointed as a Director on 31 Jul 2020 & has been associated with this company since 5 years 11 months.
Directors
21 Jun 2019
Hawa Singh Chahar was appointed as a Director on 21 Jun 2019 & has been associated with this company since 7 years 21 days.

Frequently Asked Questions about Mesco Pharmaceuticals Limited

Mesco Pharmaceuticals Limited is an active public limited company in the pharma sector based in Nanital, Uttarakhand, India. It was incorporated on 12 August 1986 (40+ years old) and is registered under CIN L24111UR1986PLC015895. Listed on BSE: 500274.

The current directors of Mesco Pharmaceuticals Limited are:

The primary industry of Mesco Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Mesco Pharmaceuticals Limited is listed on BSE with code 500274.

Mesco Pharmaceuticals Limited can be reached at the registered office: Upper Kesalton Tallital Nanital, Uttarakhand, India – 263001, or through the website mescopharma.com.

The authorised capital is ₹30 Cr, and the paid-up capital is ₹19.74 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available